发明名称 Inclusion Compounds of Fumagillol Derivative or its Salt, and Pharmaceutical Compositions Comprising the Same
摘要 The present invention relates to an inclusion compound of fumagillol derivative or its salt with hydroxypropyl-β-cyclodextrin or sulfobutylether-7-β-cyclodextrin, and pharmaceutical compositions comprising the same. The inclusion compound according to the present invention has superior water solubility and stability while exhibiting low toxicity, rendering it valuable as an anticancer agent or inhibitor of tumor metastasis.
申请公布号 US2014155348(A1) 申请公布日期 2014.06.05
申请号 US201313924768 申请日期 2013.06.24
申请人 Kim Jae Hyun;Lee Su Kyung;Choi Won Kyu;Lim Jong Lae;Ahn Soon Kil;Shin Hee Jong;Hong Chung Il 发明人 Kim Jae Hyun;Lee Su Kyung;Choi Won Kyu;Lim Jong Lae;Ahn Soon Kil;Shin Hee Jong;Hong Chung Il
分类号 A61K47/48;A61K31/336 主分类号 A61K47/48
代理机构 代理人
主权项 1. An inclusion compound of fumagillol derivative of the following Formula 1 or its salt with hydroxypropyl-β-cyclodextrin or sulfobutylether-7-β-cyclodextrinWherein, X is hydroxy, Y is halogen, or X and Y together forms oxirane ring; B is O or H2; and R1, R2, R3, R4 and R5 independently represent hydrogen, hydroxy, acetoxy, C1-C6 alkyl, C1-C6 alkoxy, amino, alkylamino, dialkylamino, aminoalkyl, alkylaminoalkyl, dialkylaminoalkyl, aminoalkoxy, alkylaminoalkoxy, dialkylaminoalkoxy, halogen, cyano, trifluoromethyl, nitro, formyl, acetamido, methyleneoxycarboxy, methylenedioxy or ethylenedioxy group, provided that R1, R2, R3, R4 and R5 cannot be hydrogen at the same time.
地址 Seoul KR